Clinical trial
A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus
NCT00367445 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00367445 |
|---|---|
| Title | A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus |
| Official title | A 1 Month, Open-Label Inpatient, Randomized Cross-Over Trial Assessing The Impact Of Dry Powder Inhaled Insulin (Exubera) On 24-Hour Glycemic Control Compared To Insulin Glargine (Lantus) In Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled On A Combination Of Two Oral Agents |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Inhaled Human Insulin (Exubera), Insulin Glargine (Lantus) |
| Enrollment | 30 |
| Start date | Sep 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Aug 22, 2006 |
| Last update posted | Jan 29, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: